Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection
- 18 June 2021
- journal article
- research article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 58 (5) , 520-527
Abstract
Background: The variability of Covid-19 severity between patients has driven efforts to identify prognosticating laboratory markers that could aid clinical decision-making. Procalcitonin is classically used as a diagnostic marker in bacterial infections, but its role in predicting Covid-19 disease severity is emerging. We aimed to identify the association between procalcitonin and Covid-19 disease severity in a critical care setting and whether bacterial co-infection is implicated. Methods: We retrospectively reviewed Covid-19 patients with procalcitonin concentrations measured in a critical care setting at our institution between February and September 2020. Laboratory markers including peak procalcitonin values and a range of bacterial culture results were analysed. Outcomes were the requirement and duration of invasive mechanical ventilation as well as inpatient mortality. Results: In total, 60 patients were included; 68% required invasive mechanical ventilation and 45% died as inpatient. Univariate analysis identified higher peak procalcitonin concentrations significantly associated with both the requirement for invasive mechanical ventilation (OR: 3.2, 95% CI 1.3–9.0, P = 0.02) and inpatient mortality (OR: 2.6, 95% CI 1.1–6.6, P = 0.03). Higher peak procalcitonin concentrations was an independent predictor of mortality on multivariate analysis (OR 3.7, 95% CI 1.1–12.4, P = 0.03). There was a significant positive correlation between increased peak procalcitonin concentrations and duration on invasive mechanical ventilation. No significant difference was found between peak procalcitonin concentrations of patients with positive and negative bacterial cultures. Conclusions: Elevated procalcitonin concentrations in Covid-19 patients are associated with respiratory failure requiring prolonged invasive mechanical ventilation and inpatient mortality. This association may be independent of bacterial co-infection.Keywords
This publication has 16 references indexed in Scilit:
- Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysisClinica Chimica Acta, 2020
- Potential association between COVID-19 mortality and health-care resource availabilityThe Lancet Global Health, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Reappraisal of Ventilator-Free Days in Critical Care ResearchAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: a retrospective observational studyJournal of Surgical Research, 2018
- Procalcitonin for diagnosing and monitoring bacterial infections: for or against?Clinical Chemistry and Laboratory Medicine (CCLM), 2018
- The reality of patients requiring prolonged mechanical ventilation: a multicenter studyRevista Brasileira de Terapia Intensiva, 2015
- Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and futureBMC Medicine, 2011
- C-reactive protein: a critical updateJournal of Clinical Investigation, 2003
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987